Murine leukemia virus particles assembled in actinomycin D-treated cells were detected by determination of reverse transcriptase [RNA-dependent DNA polymerase (nucleotidyltransferase)] activity and by radioimmunoassay of the major virion protein, p30. The levels of enzyme activity and p30 protein were both 30-40% relative to the control over an 8 hr period, whereas after 3 or 4 hr infectivity was reduced by 95%. Thus, virions produced in the absence of RNA synthesis represent a fairly homogeneous population of defective particles.
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Although RNA synthesis is not necessary for virus assembly, protein synthesis is required. Treatment of cells with 10 j;g/ml of cycloheximide reduced virus production by 80-85% within 2 hr, and by greater than 95% at later times. As might be expected from this finding, viral protein synthesis accompanies virus assembly in actinomycin D-treated cells. Newly synthesized proteins associated with the defective particles were identical with those found in standard virions and were present in the correct proportions. The results demonstrate that viral mRNA persists in cells in which RNA synthesis is blocked and continues to direct viral protein synthesis with a functional half-life of approximately 6-8 hr. Since viral mRNA is not packaged in virions even when viral RNA synthesis is shut off [Levin et aL (1974) J. Virol. 14, 152-1611, we propose that murine leukemia virus-infected cells contain two nonequilibrating pools of intracellular viral RNA molecules, one associated with polyribosomes and one which is encapsidated into extracellular particles. Virus-specific RNA found in association with polyribosomes of murine leukemia virus (MuLV)-producing cells consists of two major size classes, 35S and 20S RNA (1) (2) (3) , and a minor 14S RNA component (2) . These RNA molecules are presumed to be viral mRNA species. However, aside from their molecular size and distribution in free or membrane-bound polyribosomes (2, 3) , very little is known about their biological properties or metabolism in the cell.
One question which has not yet been studied, although it is of obvious interest, is that of viral mRNA stability. Recent- ly, we developed a system which provides an approach to this problem. In Assays. The extracellular fluids were clarified by sedimentation at 800 X g for 20 min. A portion was taken for measurement of infectivity by the XC plaque assay (6) . The remaining fluids were concentrated 50-fold by high-speed centrifugation (4). Replicate portions were assayed for the p3O viral protein with a radioimmunoassay (7) and for DNA polymerase activity in response to poly(rA).(dT)12_18 (4) .
The concentration of Mn++ in the enzyme assay was 0.5 mM. The XC tests were expertly performed by Elizabeth von Kaenel, Microbiological Associates. The radioimmunoassays were kindly performed in Dr. Wade Parks' laboratory, National Cancer Institute.
Virus Purification. Extracellular fluids were clarified as described above and were then concentrated by ammonium sulfate precipitation (4) . The resuspended pellet (10 ml) was added to a tube containing 4 Gel Electrophoresis. Samples were heated at 100°for 1-2 min and were then applied to a 15% polyacrylamide slab gel overlaid with a 3% stacking gel as described by Maizel for the "SDS-disc" system (8) . The gels were run at 45 V for [17] [18] hr at-room temperature. Marker proteins and some viral protein bands were detected by Coomassie blue staining (8) . Radioactivity was determined by slicing individual lanes in 1 mm slices, incubating the slices overnight at 550 with 0.25 ml of 30% (wt/wt) hydrogen peroxide, and then counting in 10 ml of Aquasol in a Beckman liquid scintillation spectrometer.
RESULTS
Kinetics of Virus Production in Actinomycin D-Treated Cells. Defective MuLV particles are generated in the presence of actinomycin D (4) . In order to find conditions which maximize the yield of defective particles relative to standard virions, the kinetics of virus production were measured in cells incubated with 1 ,tg/ml of actinomycin D. Standard virions were detected by an infectivity assay (6) . Total virus particles were detected by the presence of the p30 protein, the major structural protein of MuLV, and by assay of reverse transcriptase activity. The enzyme activity was inhibited by antisera directed against authentic MuLV DNA polymerase and exhibited primer/template preferences characteristic of the viral enzyme (B. I. Gerwin and J. G. Levin, unpublished observations).
As may be seen from Table 1 , reverse transcriptase activity was reduced 2.5-fold during the first 2 hr of treatment with actinomycin D, but remained at a fairly constant level over the next 6 hr. Almost identical kinetics were observed for the p30 protein, and between 2 and 8 hr of incubation the level of this protein was also 30-40% of the control value. In contrast, infectivity was rapidly reduced by actinomycin D treatment and within 3 Fig. 1 shows that cycloheximide treatment leads -to a sharp decrease in virus particle production. By 2 hr, the relative amounts of infectivity, reverse transcriptase activity, and p30 protein were all reduced by 80-85%, and at later times the inhibition was 95% or greater. Similar findings have been reported by Paskind et al. (9) . In other experiments (not shown), we have found that virus production was decreased by 50% during the first hour of incubation with the drug. Lowering the concentration of cycloheximide to 0.1 ,ug/ml resulted in 50% inhibition by 3 hr and 80-90% thereafter. These results demonstrate that virus production is strongly dependent upon protein synthesis.
Further evidence for this conclusion was provided by electron microscopy (kindly performed by Dr. Philip Grimley). Thin sections of cycloheximide-treated cells revealed few budding particles at the cell surface and only occasional extracellular virions, again in striking contrast to the situation with actinomycin D (4). At no time was there ever an accumulation of particles at the cell surface and by 8 hr no particles could be seen, presumably because the number was below the limits of detection. These findings are in accord with observations by Luftig et al. (11) and indicate that cycloheximide inhibits virus assembly rather than terminal steps involved in particle release. (Fig. 2) . The samples were analyzed by coelectrophoresis in a 15% polyacrylamide slab gel. As illustrated in Fig. 2 , the electrophoretic patterns of the control and actinomycin D samples were essentially identical. Eight major peaks were obtained and these corresponded to the following virus structural proteins: gp69/71 and gp45, the two major glycoproteins; p7O, a protein which has an electrophoretic mobility similar to bovine serum albumin and which is thought to be a precursor of p3O (18); p15E, an envelope protein (19-21) ; p30, the major core protein; and p15, p12, and p1O. Identification of these peaks Fig. 2 , these proteins sometimes migrate as a single peak in this (Fig. 3 ) and other gel systems (21) . Table 2 presents a quantitative analysis of the data in Fig.  2 and shows the proportion of major virion proteins relative to the amount of p3O. In almost every case the relative proportion of these proteins was the same for both the control and actinomycin D samples. There was approximately 1.5-fold more material in the glycoprotein peaks of the actinomycin D sample compared with the control. However, this difference may not be too significant, since recovery of the glycoproteins varies with different virus preparations.
Additional evidence that the peaks shown in Fig. 2 represent authentic viral proteins was provided by immunoprecipitation of the proteins prior to gel electrophoresis (Fig. 3) . In this experiment, control and actinomycin D virions were labeled with [3H]leucine. Although the total radioactivity of the actinomycin D preparation was 40% of the control (see above), the amount of radioactive material immunoprecipitated and subsequently applied to the gel was the same in both cases. As may be seen from Fig. 3 , the electrophoretic patterns of the control and actinomycin D samples were virtually superimposable and showed great similarity to the patterns displayed in Fig. 2 . Furthermore, with only two exceptions (p70, which was slightly higher in the control, and gp45, which was again somewhat higher in the actinomycin D sample), the amount of radioactivity in the major peaks was the same for both samples. It should be noted that for both the control and actinomycin D samples the proportion of individual virus proteins relative to p30 differed in several instances from the values given in Table 2 . This variation probably reflects differences in the immunogenicities of various viral proteins.
In considering the results presented in Figs. 2 (4, 9) . In contrast, protein synthesis is required for assembly, since treatment with an inhibitor such as cycloheximide leads to a rapid decrease in virus production (ref. 9 and Fig. 1 (33) . In preliminary experiments using a radioimmunoassay (7), we have observed that intracellular levels of p30 decline rather slowly during incubation with cycloheximide; e.g., at 2 hr the concentration is 50% relative to the control and by 6 or 8 hr, 25-30% relative to the control. These results are not due to an unusual accumulation of p30 precursor molecules, since processing of viral precursors can occur in the presence of cycloheximide (29, 32 (Figs. 2 and 3 ). In addition, the relative proportion of individual virus proteins is essentially the same in control and actinomycin D preparations ( Table 2) The results demonstrate that although RNA synthesis is blocked in cells incubated with actinomycin D, viral mRNA Biochemistry: Levin and Rosenak continues to direct the synthesis of proper viral proteins for many hours after the cessation of RNA synthesis. The functional half-life of viral mRNA can be estimated from our experiments as approximately 6-8 hr. However, since actinomycin D is thought to have an inhibitory effect on initiation of protein synthesis (16, 34) (9) on the basis of our earlier data (4) and their own observation that noninfectious MuLV particles are assembled in the presence of actinomycin D (9) . The concept of independent RNA pools can be defined experimentally in our system by the finding that virion or genomic RNA has a half-life of approximately 1.5-2 hr (4, 10, 25) , whereas the half-life of viral mRNA is approximately 6-8 hr.
In addition to giving some insight into the metabolism of MuLV RNA in chronically infected cells, the actinomycin D system also provides a unique perspective on the process of virus assembly. In viewing the results presented here and previously, one is particularly struck by the fact that an apparently total deficit in high-molecular-weight viral RNA is compatible with the assembly. of particles having many of the characteristics of standard virions (4) . For example, as noted earlier (4), the defective particles from actinomycin D-treated cells sediment with a buoyant density of 1.16 g/cm3 in sucrose gradients, have the typical morphology of type C virions, and contain the reverse transcriptase enzyme. Even more striking, perhaps, is the current finding that all of the virus structural proteins are present in the particles and in the appropriate amounts. The evidence from the actinomycin D system strongly favors the idea that the presence of the viral RNA genome, at least in its usual form, is not essential for directing the assembly of virus proteins into virus particles.
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